← Back to patent-cliff list
CAS 40473-01-6
2-bromo-5-chloropyridine
Codes: AQW-051-002
Application context (from source-drug indications)
AnxietyAQW-051表现焦虑AQW-051Alzheimer's diseaseAQW-051Mild cognitive impairmentAQW-051SchizophreniaAQW-051运动障碍AQW-051
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| AQW-051 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
AQW-051→5-chloropyridin-2-amine→2-bromo-5-chloropyridine→p-tolylboronic acid→5-chloro-2-(p-tolyl)pyridine→(R)-quinuclidin-3-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.